ANS TESTING OFFERS TREMENDOUS VALUE TO A PRACTICE
Reduces the cost of overall patient care
Easy to bill multi-code diagnostics
Improves overall patient health
Fits in your existing examination
Gateway Clinical continues its commitment to recommending devices that not only provide maximum patient care but also make sense from an investment perspective.
TM FLOW SYSTEM
TM Flow as an Investment in the Future of Your Practice:
For physicians, the revenue from the TM Flow can be dramatic. Most primary care practices are seeing 20 patients a day, most of whom would qualify for this diagnostic test.
By simply implementing this test into patients’ annual physicals, it is possible to add significant revenue to the bottom line of the practice.
Patients with a history of smoking, hypertension, obesity or diabetes can qualify for more frequent examinations. Please check the reimbursement guidelines for your particular locality for exact totals.
Considering that most typical investments return less than 10% annually, Why not invest in your practice instead?
GATEWAY CLINICAL OFFERS FLEXIBLE FINANCING OPTIONS TO MEET YOUR NEEDS.
PROVEN CARE STANDARDS
Testing of the autonomic nervous system is a recommended standard of care by the American Diabetes Association for patients with Type 1 and Type 2 diabetes.
The American Heart Association Practice Guidelines for the management of patients with Peripheral artery disease include the measurement of ankle brachia I index (ABI) in adults 50+ years old with history of smoking diabetes, or circulation problems, and all adults above 70 years old.*
*Ankle brachial index screening in asymptomatic older adults, Am Heart J. 2011 May; 161(5): 979-985.
NON INVASIVE ACCURACY
State of the art devices that perform a series of non-invasive tests which aid in the identification and early detection of autonomic nervous system & arterial dysfunction related to disorders and disease complications.
Quantitative assessments of the autonomic nervous system (ANS)
Distinguishes between early and late stages of autonomic neuropathy
Test for cardiovascular autonomic neuropathy (CAN)
Test for diabetic autonomic neuropathy (DAN) Diabetes Management
*The above check list of CPT Codes are only suggested according to the cleared intended use of each LD Technology product, and it cannot be considered as a part of the device performances. The practitioner is solely responsible for compliance in the use of CPT codes and related ICD-10’s according to the guidelines established by the AMA (American Medical Association) and CMS (Center for Medicare and Medicaid Services) Central Office per state or region. LD TECHNOLOGY shall not be liable for any changes from the AMA and/or CMS and/or for any financial damage resulting from the suggested CPT in case of practitioner’s Audit.
Schedule a Consultation